Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 60,000 shares at $38.59 ($2.3M) on 2022-03-29, disclosed to the SEC on 2022-03-30.
Open-market sale of $2.3M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |